Crinetics Pharmaceuticals Balance Sheet (2017-2026) | CRNX

Balance Sheet Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Accumulated Depreciation (Quarter)
3.25M3.48M3.72M3.94M3.81M4.08M4.37M4.60M4.88M5.07M5.48M6.23M6.98M7.73M8.64M9.59M
Receivables - Accured (Quarter)
1.40M3.10M8.30M7.20M8.40M6.30M7.80M9.00M
Assets
Current Assets
Cash & Equivalents (Quarter)
178.77M161.54M201.19M145.55M62.29M30.91M33.97M41.19M39.55M142.79M54.90M395.92M302.16M317.27M264.55M94.57M1,200.00M110.90M101.54M114.34M
Receivables - Net (Quarter)
0.59M5.68M
Receivables - Other (Quarter)
0.11M0.09M0.55M0.62M1.16M0.09M1.35M1.27M0.90M2.62M3.05M3.17M3.48M0.09M8.31M7.22M8.38M6.34M7.76M8.96M
Receivables (Quarter)
8.31M8.35M14.64M
Work In Process (Quarter)
2.00M3.04M
Finished Goods (Quarter)
0.02M0.03M
Inventory (Quarter)
2.02M3.06M
Prepaid Assets (Quarter)
7.59M10.65M0.91M1.62M0.29M1.65M1.93M0.58M0.37M1.29M0.86M3.56M0.33M14.92M23.65M16.43M20.40M28.48M3.46M22.36M
Current Assets (Quarter)
211.35M203.97M344.72M328.25M416.29M378.32M345.18M305.40M284.81M575.76M574.15M917.23M874.78M877.59M1,375.39M1,291.06M1,217.26M1,121.28M1,048.34M1,322.41M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)
3.00M2.90M2.83M2.67M3.15M3.56M3.50M3.27M3.22M9.76M10.88M11.87M12.25M11.71M12.07M12.63M14.67M14.38M14.30M13.50M
Long-Term Deferred Tax (Quarter)
291.54M
Other Non-Current Assets (Quarter)
0.50M0.50M0.50M0.50M0.50M1.30M1.30M1.30M1.30M1.30M1.30M1.30M1.30M1.30M0.80M1.30M1.30M1.30M22.33M0.80M
Non-Current Assets (Quarter)
5.57M5.39M6.29M5.04M5.45M6.56M6.99M8.61M8.44M65.78M61.20M60.92M60.76M59.79M59.20M70.27M72.31M74.76M77.92M78.91M
Assets (Quarter)
216.93M209.36M351.01M333.29M421.73M384.88M352.18M314.01M293.25M641.54M635.35M978.15M935.53M937.37M1,434.59M1,361.33M1,289.57M1,196.03M1,126.26M1,401.32M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
7.14M6.15M3.42M12.13M17.13M13.49M6.88M5.89M20.82M21.93M6.55M28.68M24.00M18.27M21.47M9.84M11.32M33.67M41.77M37.49M
Payables (Quarter)
7.14M6.15M3.42M12.13M17.13M13.49M6.88M5.89M20.82M21.93M6.55M28.68M24.00M18.27M21.47M9.84M11.32M33.67M41.77M37.49M
Accumulated Expenses (Quarter)
3.89M5.38M6.59M4.45M5.45M7.72M9.08M6.83M8.60M12.88M14.52M14.83M20.38M26.19M28.89M16.61M21.80M32.40M35.58M25.79M
Other Accumulated Expenses (Quarter)
0.89M0.91M0.94M0.96M1.77M0.43M0.34M0.98M0.52M0.99M3.27M0.49M1.08M0.51M0.90M1.67M1.80M
Current Leases (Quarter)
0.94M1.02M1.05M1.08M1.11M3.99M4.17M5.79M7.45M7.41M7.15M6.88M6.61M6.44M6.49M6.54M
Current Deferred Revenue (Quarter)
2.71M9.43M2.32M8.34M7.74M7.15M1.66M6.81M7.20M6.88M1.69M6.88M6.52M1.90M1.64M1.24M1.27M
Total Current Liabilities (Quarter)
11.92M12.44M15.99M20.26M26.11M24.56M27.72M26.32M32.61M40.46M43.94M51.77M54.38M53.56M59.68M57.31M68.40M74.16M85.07M71.09M
Non-Current Liabilities
Non-Current Deffered Revenue (Quarter)
0.01M0.01M7.16M6.89M6.65M6.10M5.62M5.07M5.14M4.75M4.74M4.32M5.20M4.70M4.31M3.99M4.11M3.81M3.35M
Preferred Stock Liabilities (Quarter)
Operating Leases (Quarter)
3.56M3.32M3.07M2.82M2.56M2.30M2.02M1.74M1.46M48.18M47.55M46.71M45.87M45.13M44.57M43.94M43.33M49.14M42.05M41.32M
Non-Current Deferred Tax Liability (Quarter)
0.45M9.80M9.75M
Other Non-Current Liabilities (Quarter)
0.20M0.51M0.83M1.77M2.33M2.89M3.24M4.93M
Total Non-Current Liabilities (Quarter)
96.25M104.57M103.88M108.96M105.56M115.71M120.97M130.93M115.75M
Total Liabilities (Quarter)
15.49M15.77M19.07M30.24M35.57M33.51M35.85M33.68M39.14M93.79M96.25M103.22M104.77M104.39M109.79M107.33M118.05M123.86M134.17M120.68M
Shareholder's Equity
Common Equity (Quarter)
201.44M193.59M331.94M303.04M386.17M351.37M316.33M280.33M254.12M547.75M539.11M874.93M830.76M832.98M1,324.81M1,254.00M1,171.53M1,072.17M992.08M1,280.65M
Shareholder's Equity (Quarter)
201.44M193.59M331.94M303.04M386.17M351.37M316.33M280.33M254.12M547.75M539.11M874.93M830.76M832.98M1,324.81M1,254.00M1,171.53M1,072.17M992.08M1,280.65M
Liabilities and Shareholders Equity (Quarter)
216.93M209.36M351.01M333.29M421.73M384.88M352.18M314.01M293.25M641.54M635.35M978.15M935.53M937.37M1,434.59M1,361.33M1,289.57M1,196.03M1,126.26M1,401.32M
Treasury Shares (Quarter)
0.11M0.11M0.11M1.03M
Retained Earnings (Quarter)
-216.60M-244.46M-0.38M-309.90M-3.62M-394.18M-439.17M-485.17M-1.71M-593.60M0.98M-720.60M-794.69M2.04M0.96M-1048.88M-1200.00M-1294.61M-1417.43M-1545.27M
Shares Outstanding (Quarter)
37.68M38.62M47.60M4.78M53.72M53.80M53.88M53.99M54.68M66.71M68.17M78.54M79.32M80.84M92.93M93.53M94.13M94.55M95.58M105.31M